The Recall Desk
HighFDA (Drugs)·D-0418-2025·Announced 2025-05-21

[pending] La Roche-Posay Laboratoire Dermatologique Effaclar Dermatological Acne System, 3 Step Acne Routine K

Pending LLM rewrite. Source: FDA_DRUG D-0418-2025.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: Pending LLM scoring against the rubric.

Plain-English summary

cGMP Deviations: The recall was initiated due to detected trace levels of benzene in a specific lot of this product lot (MYX46W), however out of an abundance of caution, the firm voluntarily recalled all La Roche-Posay Effaclar Duo Dual Action Acne Treatment lots.

The recalled product

Product
La Roche-Posay Laboratoire Dermatologique Effaclar Dermatological Acne System, 3 Step Acne Routine Kit, Medicated Gel Cleanser 3.4 fl. oz. (100 mL) Tube, Clarifying Solution 3.4 fl. oz. (100 mL) Tube, Dual Action Acne Treatment 0.7 fl. oz. (20 mL: UPC 883140035275) Tube, (benzoyl
Manufacturer
L'Oreal USA
Category
Drug — Drugs

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (20)

  • Lot #s
  • Expiration Dates: MYX30W
  • Exp 03/31/2025 MYX32W
  • Exp 03/31/2025 MYX33W
  • Exp 03/31/2025 MYX41W
  • Exp 04/30/2025 MYX42W
  • Exp 04/30/2025 MYX43W
  • Exp 04/30/2025 MYX44W
  • Exp 04/30/2025 MYX45W
  • Exp 04/30/2025 MYX50W
  • Exp 05/31/2025 MYX51W
  • Exp 04/30/2025 MYX52W
  • Exp 04/30/2025 MYX53W
  • Exp 05/31/2025 MYX70W
  • Exp 07/31/2025 MYX80W
  • Exp 07/31/2025 MYX81W
  • Exp 07/31/2025 MYX90W
  • Exp 08/31/2025 MYX91W
  • Exp 08/31/2025 MYX92W
  • Exp 08/31/2025 MYX93W

Distribution

Distributed nationwide across the United States.

Related recalls

Same category